Arteris CFO granted 41,217 restricted stock units

Arteris, Inc. reported that its VP and Chief Financial Officer, Nicholas B. Hawkins, acquired 41,217 restricted stock units as an equity award.

Rhea-AI Filing Summary

Arteris, Inc. reported that its VP and Chief Financial Officer, Nicholas B. Hawkins, acquired 41,217 restricted stock units as an equity award. Each RSU represents one share of common stock and vests 1/16 on 4/1/2026, then in equal quarterly installments. Following this grant, he holds 123,484 shares of common stock in total.

Insider Trade Summary

Grant/Award: 41,217 shares

Grant/Award 1 txn

Insider Hawkins Nicholas B.

Role VP and Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	41,217	$0.00	$0.00

Holdings After Transaction: Common Stock — 123,484 shares (Direct)

Footnotes (1)

1. F1. Includes 41,217 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 1/16th of the total RSUs on 4/1/2026 and in equal quarterly installments thereafter. The RSUs have no expiration date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Arteris (AIP) disclose for Nicholas B. Hawkins?

Arteris disclosed that VP and CFO Nicholas B. Hawkins received a grant of 41,217 restricted stock units. These RSUs are equity awards that convert into common shares over time as they vest, aligning his compensation more closely with company performance.

How many restricted stock units were granted to the Arteris (AIP) CFO?

The Arteris CFO, Nicholas B. Hawkins, was granted 41,217 restricted stock units. Each RSU represents a contingent right to receive one share of Arteris common stock, subject to the vesting schedule described in the award terms and subsequent service conditions.

What is the vesting schedule for Nicholas B. Hawkins’ RSUs at Arteris (AIP)?

The RSUs granted to Nicholas B. Hawkins vest 1/16 of the total on April 1, 2026. The remaining units vest in equal quarterly installments thereafter, meaning the award gradually converts into common shares over multiple quarters as the vesting conditions are satisfied.

Do the Arteris (AIP) RSUs granted to the CFO have an expiration date?

The RSUs granted to the Arteris CFO do not have an expiration date. They remain outstanding until they vest or are otherwise forfeited under the terms of the award, eventually settling into common shares if all vesting conditions are met.

How many Arteris (AIP) shares does the CFO own after this RSU grant?

After the RSU grant, Nicholas B. Hawkins is reported to beneficially own 123,484 shares of Arteris common stock. This figure includes the 41,217 restricted stock units, each representing a contingent right to receive one share upon satisfaction of the vesting schedule.

Was the Arteris (AIP) CFO’s RSU transaction a market purchase or sale?

The RSU transaction for the Arteris CFO was a grant, not a market trade. The Form 4 lists the transaction code as a grant or award acquisition, with a price per share of zero, indicating equity compensation rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 09:21 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hawkins Nicholas B.

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A(1)		41,217	A	$0.00	123,484	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 41,217 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 1/16th of the total RSUs on 4/1/2026 and in equal quarterly installments thereafter. The RSUs have no expiration date.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B.	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.